DIM (3,3'-diindolylmethane)

Name	AC	CK
Estrogen Dysregulation: 2/4/16 hydroxyestrone ratios	1	10
Breast Cancer	2	3
Breast Cancer: Lung Metastasis	1	2
Pancreatic Cancer	1	1
Prostate Cancer	1	1

Name

Focus

Estrogen Dysregulation: 2/4/16 hydroxyestrone ratios

Breast Cancer

Breast Cancer: Lung Metastasis

Pancreatic Cancer

Prostate Cancer

Name	AC	CK	Focus
Anti-metastatic	1	2
Chemosensitizer	1	1

Name

Focus

Anti-metastatic

Chemosensitizer

[+]

DIM improves the estrogen profile in postmenopausal women with a history of early-stage breast cancer. Jan 01, 2004

Click here to read the entire abstract

Pubmed Data : Nutr Cancer. 2004;50(2):161-7. PMID: 15623462

Article Published Date : Jan 01, 2004

Study Type : Human Study

Additional Links

Substances : DIM (3,3'-diindolylmethane)

Diseases : Estrogen Dysregulation: 2/4/16 hydroxyestrone ratios

[+]

DIM inhibits lung metastasis of mammary cancer cells in mice. Oct 28, 2009

Click here to read the entire abstract

Pubmed Data : J Nutr. 2009 Oct 28. PMID: 19864400

Article Published Date : Oct 28, 2009

Study Type : Animal Study

Additional Links

Substances : DIM (3,3'-diindolylmethane)

Diseases : Breast Cancer, Breast Cancer: Lung Metastasis

Pharmacological Actions : Anti-metastatic

[+]

DIM (3,3'-diindolylmethane) sensitizes breast tumors to chemotherapy. Oct 01, 2007

Click here to read the entire abstract

Pubmed Data : Mol Cancer Ther. 2007 Oct;6(10):2757-65. Epub 2007 Oct 3. PMID: 17913854

Article Published Date : Oct 01, 2007

Study Type : In Vitro Study

Additional Links

Substances : DIM (3,3'-diindolylmethane)

Diseases : Breast Cancer

Pharmacological Actions : Chemosensitizer

Additional Keywords : Drug-Plant-Vitamin Synergies

[+]

DIM inhibits prostate cancer cell growth. May 01, 2000

Click here to read the entire abstract

Pubmed Data : Carcinogenesis. 2000 May;21(5):921-7. PMID: 17047070

Article Published Date : May 01, 2000

Study Type : In Vitro Study

Additional Links

Substances : DIM (3,3'-diindolylmethane)

Diseases : Prostate Cancer

[+]

The chemotherapeutic activity of erlotinib is potentiated by 3,3' diindolymethane (DIM) against pancreatic cancer, in vitro and in vivo. Jun 01, 2008

Click here to read the entire abstract

Pubmed Data : Mol Cancer Ther. 2008 Jun;7(6):1708-19. PMID: 18566242

Article Published Date : Jun 01, 2008

Study Type : In Vitro Study

Additional Links

Substances : DIM (3,3'-diindolylmethane)

Diseases : Pancreatic Cancer

Additional Keywords : Chemotherapeutic Synergy: Erlotinib, Drug-Plant-Vitamin Synergies

DIM (3,3'-diindolylmethane)

Focus Your Research

Click any topic below to filter + focus research

View the Evidence:
5 Abstracts with DIM (3,3'-diindolylmethane) Research

Limited to Members Only

Currently Available Sorting Options

DIM improves the estrogen profile in postmenopausal women with a history of early-stage breast cancer. Jan 01, 2004

Click here to read the entire abstract

DIM inhibits lung metastasis of mammary cancer cells in mice. Oct 28, 2009

Click here to read the entire abstract

DIM (3,3'-diindolylmethane) sensitizes breast tumors to chemotherapy. Oct 01, 2007

Click here to read the entire abstract

DIM inhibits prostate cancer cell growth. May 01, 2000

Click here to read the entire abstract

The chemotherapeutic activity of erlotinib is potentiated by 3,3' diindolymethane (DIM) against pancreatic cancer, in vitro and in vivo. Jun 01, 2008

Click here to read the entire abstract

Print Options

DIM (3,3'-diindolylmethane) jQuery(function ($) { $(".node-field-image").click(function () { $(".node-field-image").toggleClass("open"); }); $(".node.topic>.colfull").click(function () { $(".node.topic>.colfull").toggleClass("open"); }); })

Focus Your Research

Click any topic below to filter + focus research

DIM (3,3'-diindolylmethane) is a Sub of the following Topic

View the Evidence: 5 Abstracts with DIM (3,3'-diindolylmethane) Research

Limited to Members Only

Currently Available Sorting Options

DIM improves the estrogen profile in postmenopausal women with a history of early-stage breast cancer. Jan 01, 2004

Click here to read the entire abstract

DIM inhibits lung metastasis of mammary cancer cells in mice. Oct 28, 2009

Click here to read the entire abstract

DIM (3,3'-diindolylmethane) sensitizes breast tumors to chemotherapy. Oct 01, 2007

Click here to read the entire abstract

DIM inhibits prostate cancer cell growth. May 01, 2000

Click here to read the entire abstract

The chemotherapeutic activity of erlotinib is potentiated by 3,3' diindolymethane (DIM) against pancreatic cancer, in vitro and in vivo. Jun 01, 2008

Click here to read the entire abstract

Print Options

DIM (3,3'-diindolylmethane)

View the Evidence:
5 Abstracts with DIM (3,3'-diindolylmethane) Research